This Article Full Text Full Text (PDF) All Versions of this Article: 37/1/116    most recent 01.STR.0000195044.44442.e0v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuhle, S. Articles by deVeber, G. Search for Related Content PubMed PubMed Citation Articles by Kuhle, S. Articles by deVeber, G. Pubmed/NCBI databases Medline Plus Health Information Stroke Related Collections Heparin Coumarins Thrombophilia Acute Cerebral Infarction Cerebral Venous Thrombosis Stroke in Children and the Young Anticoagulants Antiplatelets Related Article

(Stroke. 2006;37:116.)
© 2006 American Heart Association, Inc.

Original Contributions

Urgent Clinical Challenges in Children With Ischemic Stroke

Analysis of 1065 Patients From the 1-800-NOCLOTS Pediatric Stroke Telephone Consultation Service

Stefan Kuhle, MD; Lesley Mitchell, MSc; Maureen Andrew, MD; Anthony K. Chan, MBBS; Patricia Massicotte, MD; Margaret Adams, RN Gabrielle deVeber, MD

From the Department of Pediatrics (S.K., L.M., P.M.), Thrombosis Program, Stollery Children’s Hospital, Edmonton, Alberta, Canada; Department of Pediatrics (M. Andrew, deceased), Division of Hematology, Hospital for Sick Children, Toronto Ontario, Canada; Department of Pediatrics (A.K.C.), Division of Hematology, Children’s Hospital at Chedoke McMaster, Hamilton, Ontario, Canada; and Department of Pediatrics (M. Adams, G.d.), Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.

Correspondence to Gabrielle deVeber, MD, Department of Pediatrics, Division of Neurology, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, M5G 1X8 Canada. E-mail deveber{at}sickkids.ca

Background and Purpose— Clinical trials are lacking in pediatric stroke. As a result, physicians caring for children with stroke face significant challenges. The patient characteristics and specific nature of clinical challenges facing practicing clinicians can inform the design of and priorities for developing relevant clinical trials.

Methods— Physicians consulted the 1-800-NOCLOTS toll-free pediatric stroke telephone consultation service on children (birth to 18 years) with ischemic stroke. Pediatric neurologist or hematologists provided telephone consultation and documented caller and patient characteristics, antithrombotic treatments and callers’ questions for entry into a computerized database. Children referred from January 1, 1995 to January 1, 2004, comprised the study cohort.

Results— Stroke consults were completed on 1065 children located predominantly in the United States (76%). Children had arterial ischemic stroke (AIS; 679; 64%) or cerebral sinovenous thrombosis (CSVT; 386; 36%) and were 54% male and 16% neonates. Risk factors and antithrombotic agents (none, aspirin, warfarin, and heparins) differed by stroke type. In 60% of patients, callers had not initiated antithrombotic therapy. Callers’ questions for both stroke types usually concerned treatment selection (83%), but for AIS, questions more frequently (P<0.0001) concerned the selection and interpretation of etiological investigations.

Conclusions— Research is urgently needed in pediatric stroke to provide direction for management in "real-life" settings. Research efforts should address the unique challenges within different stroke types and include observational studies addressing investigation of the child with AIS. For AIS and CSVT, randomized controlled trials investigating the efficacy of antithrombotic treatment are urgently needed.

Key Words: infants • child • sinus thrombosis • stroke, ischemic

Related Article:

The Emerging Quandary of Childhood Stoke: Better Aim but No Magic Bullet

Heather J. Fullerton
Stroke 2006 37: 3. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				W. Lo, J. Stephens, and S. Fernandez Pediatric Stroke in the United States and the Impact of Risk Factors J Child Neurol, February 1, 2009; 24(2): 194 - 203. [Abstract] [PDF]

				T. Domi, D. S. Edgell, B. W. McCrindle, W. G. Williams, A. K. Chan, D. L. MacGregor, A. Kirton, and G. A. deVeber Frequency, Predictors, and Neurologic Outcomes of Vaso-occlusive Strokes Associated With Cardiac Surgery in Children Pediatrics, December 1, 2008; 122(6): 1292 - 1298. [Abstract] [Full Text] [PDF]

				J. W. Heil, L. Malinowski, A. Rinderknecht, J. P. Broderick, and D. Franz Use of Intravenous Tissue Plasminogen Activator in a 16-Year-Old Patient with Basilar Occlusion J Child Neurol, September 1, 2008; 23(9): 1049 - 1053. [Abstract] [PDF]

				W. Lo, K. Zamel, K. Ponnappa, A. Allen, D. Chisolm, M. Tang, B. Kerlin, and K. O. Yeates The Cost of Pediatric Stroke Care and Rehabilitation Stroke, January 1, 2008; 39(1): 161 - 165. [Abstract] [Full Text] [PDF]

				H. J. Fullerton, Y. W. Wu, S. Sidney, and S. C. Johnston Risk of Recurrent Childhood Arterial Ischemic Stroke in a Population-Based Cohort: The Importance of Cerebrovascular Imaging Pediatrics, March 1, 2007; 119(3): 495 - 501. [Abstract] [Full Text] [PDF]

				I. M. Burger, K. J. Murphy, L. C. Jordan, R. J. Tamargo, and P. Gailloud Safety of Cerebral Digital Subtraction Angiography in Children: Complication Rate Analysis in 241 Consecutive Diagnostic Angiograms Stroke, October 1, 2006; 37(10): 2535 - 2539. [Abstract] [Full Text] [PDF]

				H. J. Fullerton The Emerging Quandary of Childhood Stoke: Better Aim but No Magic Bullet Stroke, January 1, 2006; 37(1): 3 - 3. [Full Text] [PDF]